|
WO2009023544A2
|
|
Dosage unit anion-exchange polymer pharmaceutical compositions
|
|
AU2006311765A1
|
|
Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
|
|
MX2008005662A
|
|
Azaindole compounds and use thereof as phospholipase-a2 inhibitors.
|
|
CA2627353A1
|
|
Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors
|
|
WO2007056275A2
|
|
Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors
|
|
MX2008005666A
|
|
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors.
|
|
WO2007038801A2
|
|
Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
|
|
KR20080057319A
|
|
Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
|
|
CA2583666A1
|
|
Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle
|
|
WO2006043984A2
|
|
Crosslinked amine polymers
|
|
US2008107737A1
|
|
Crosslinked amine polymers
|
|
CA2557999A1
|
|
Methods and compositions for treatment of ion imbalances
|
|
US2005239901A1
|
|
Crosslinked amine polymers
|
|
US7608674B2
|
|
Pharmaceutical compositions comprising cross-linked small molecule amine polymers
|
|
US7459502B2
|
|
Pharmaceutical compositions comprising crosslinked polyamine polymers
|
|
US2005244367A1
|
|
Phospholipase inhibitors localized in the gastrointestinal lumen
|
|
US2005209423A1
|
|
Crosslinked amine polymers
|
|
US2005096438A1
|
|
Polyamine polymers
|
